Markets:

Overview

News

Currencies

International

Treasuries

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

112.67 +4.32 (+3.99%)

Streaming Delayed Price Updated: 3:52 PM EDT, Aug 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 20, 2023

It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2

January 18, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 20, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday ↗

December 20, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 15, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 15, 2022

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 12, 2022

Via Benzinga

Monopar Announces Promising MNPR-202 Data from Ongoing National University of Singapore Collaboration

December 12, 2022

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 09, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 08, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 08, 2022

We're starting off the day with a look at the biggest pre-market stock movers that traders will want to watch on Thursday!

Via InvestorPlace

Monopar Therapeutics Highlights Encouraging Data From Early-Stage Soft Tissue Cancer Study ↗

November 16, 2022

Via Benzinga

Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial

November 16, 2022

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

Monopar Therapeutics Reports Third Quarter 2022 Financial Results and Recent Program Developments

November 10, 2022

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 07, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 02, 2022

Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 31, 2022

Gainers

Via Benzinga

Monopar Announces Timeline of Upcoming Data Events for Validive, Camsirubicin, and MNPR-202

October 27, 2022

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday ↗

November 01, 2022

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...

Via Benzinga

Monopar Announces Presentation Selected for 2022 American Society of Hematology (ASH) 64th Annual Meeting

October 19, 2022

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Announces Presentation Selected for 2022 Connective Tissue Oncology Society (CTOS) Annual Meeting

October 12, 2022

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Announces Completion of Phase 2b Enrollment and Commencement of Phase 3 Enrollment in its VOICE Trial for Severe Oral Mucositis

October 05, 2022

Interim Analysis Planned for Q1 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar to Present at Roth Inaugural Healthcare Opportunities Conference

September 28, 2022

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Therapeutics: Q2 Earnings Insights ↗

August 11, 2022

Monopar Therapeutics (NASDAQ:MNPR) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 03, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 26, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

May 16, 2022

Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

All News about Monopar Therapeutics Inc. - Common Stock

Starting at /week.